Loading...
Loading...
Loading...
Loading...
No reviews have been added for this product.
Atlas Antibodies
| Product Specifications | |
| Application | WB, ICC, IHC |
| Reactivity | Human |
| Clonality | Polyclonal |
| Host | Rabbit |
| Immunogen | MEDSHKSTTSETAPQPGSAVQGAHISHIAQQVSSLSESEESQDSSDSIGSSQKAHGILARRPSY |
| Gene Sequence | MEDSHKSTTSETAPQPGSAVQGAHISHIAQQVSSLSESEESQDSSDSIGSSQKAHGILARRPSY |
| Gene ID - Mouse | ENSMUSG00000023027 |
| Gene ID - Rat | ENSRNOG00000061088 |
| Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
| Documents & Links for Anti ATF1 pAb (ATL-HPA055069 w/enhanced validation) | |
| Datasheet | Anti ATF1 pAb (ATL-HPA055069 w/enhanced validation) Datasheet (External Link) |
| Vendor Page | Anti ATF1 pAb (ATL-HPA055069 w/enhanced validation) at Atlas Antibodies |
| Documents & Links for Anti ATF1 pAb (ATL-HPA055069 w/enhanced validation) | |
| Datasheet | Anti ATF1 pAb (ATL-HPA055069 w/enhanced validation) Datasheet (External Link) |
| Vendor Page | Anti ATF1 pAb (ATL-HPA055069 w/enhanced validation) |
| Citations for Anti ATF1 pAb (ATL-HPA055069 w/enhanced validation) – 1 Found |
| Endo, Shino; Yoshino, Yuki; Shirota, Matsuyuki; Watanabe, Gou; Chiba, Natsuko. BRCA1/ATF1-Mediated Transactivation is Involved in Resistance to PARP Inhibitors and Cisplatin. Cancer Research Communications. 2021;1(2):90-105. PubMed |
Try browsing our complete catalog of products.
Atlas Antibodies
| Product Specifications | |
| Application | WB, ICC, IHC |
| Reactivity | Human |
| Clonality | Polyclonal |
| Host | Rabbit |
| Immunogen | MEDSHKSTTSETAPQPGSAVQGAHISHIAQQVSSLSESEESQDSSDSIGSSQKAHGILARRPSY |
| Gene Sequence | MEDSHKSTTSETAPQPGSAVQGAHISHIAQQVSSLSESEESQDSSDSIGSSQKAHGILARRPSY |
| Gene ID - Mouse | ENSMUSG00000023027 |
| Gene ID - Rat | ENSRNOG00000061088 |
| Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
| Documents & Links for Anti ATF1 pAb (ATL-HPA055069 w/enhanced validation) | |
| Datasheet | Anti ATF1 pAb (ATL-HPA055069 w/enhanced validation) Datasheet (External Link) |
| Vendor Page | Anti ATF1 pAb (ATL-HPA055069 w/enhanced validation) at Atlas Antibodies |
| Documents & Links for Anti ATF1 pAb (ATL-HPA055069 w/enhanced validation) | |
| Datasheet | Anti ATF1 pAb (ATL-HPA055069 w/enhanced validation) Datasheet (External Link) |
| Vendor Page | Anti ATF1 pAb (ATL-HPA055069 w/enhanced validation) |
| Citations for Anti ATF1 pAb (ATL-HPA055069 w/enhanced validation) – 1 Found |
| Endo, Shino; Yoshino, Yuki; Shirota, Matsuyuki; Watanabe, Gou; Chiba, Natsuko. BRCA1/ATF1-Mediated Transactivation is Involved in Resistance to PARP Inhibitors and Cisplatin. Cancer Research Communications. 2021;1(2):90-105. PubMed |